News

First ever patient treated with Hemerion technology

May 12. 2017: the first ever patient treated with Hemerion technology

Five years ago, on May, 12th 2017, Pr. Nicolas Reyns delivered, for the first time ever, the therapy currently being developed by Hemerion. It was the first time that this approach was evaluated, in a frontline setup, for a patient harboring newly diagnosed glioblastoma (GBM).  The technology proposed for the treatment of GBM was based …

Fund raising

Hemerion raises €3.5 million to develop new solutions for the treatment of glioblastoma

One year after the first round of funding, Hemerion’s new €3.55 million financing will accelerate the implementation of international clinical trials for the treatment of glioblastoma, the most aggressive brain cancer. Hemerion Therapeutics has already initiated its clinical program with a successful first study in glioblastoma patients. Ultimately, the therapeutic solutions developed by Hemerion could …

Introducing Hemerion in Boston

Mission to Boston: Hemerion prepares its development in the United States

Presentation of the Hemerion technology, meeting with investors, neurosurgeons and care centers, discussions about North American regulations: Hemerion has set new milestones for its international development during a 5-day mission in Boston. With more than 13,000 new cases of glioblastoma (GBM) diagnosed each year, the United States is, along with Europe, one of the most …

Newsweek World's Best Hospitals 2022

Hemerion’s clinical contributors ranked among the 50 best hospitals in the world

Newsweek released its annual World’s Best Hospitals 2022 on Wednesday, March 2.  The 2022 edition ranks Hemerion’s clinical contributors in the TOP 100 healthcare centers: an international recognition of the quality of their care and the clinical excellence of their medical teams. An international ranking based on clinical excellence Launched in 2019, Newsweek’s “World’s Best …

Surgeon using Hemerion laser device

2021 / A year of fighting cancer

Prototypes, clinical results, hiring, scientific communications, training of neurosurgeons, awards: the year 2021 has been hectic for Hemerion’s teams, who are engaged in an essential fight against cancer, particularly glioblastoma. Major advances in technology Hemerion has finalized the production of prototypes of its Heliance technology: a decisive step in the implementation of new clinical trials. …

Pr Nicolas Reyns, neurosurgeon, co-founder of Hemerion

Intraoperative Visualization and the Connectome: Pr Reyns, Hemerion co-founder,  to present its experience with fluorophores and photoactive molecules

In December, Hemerion will sponsor a two-day virtual conference organized by the Society for Neuro-Oncology (SNO). Pr. Nicolas Reyns MD, PhD (University Hospital of Lille, France), co-founder of Hemerion, will participate in this conference to share our team’s experience and innovations with photoactive drugs used to enhance neurosurgery outcomes in patients. The virtual conference chaired …

Maximilen Vermandel, co-fournder of Hemerion

Hemerion awarded an Innovation Prize by Voisin Consulting Life Sciences Neighborhood

Hemerion received the Best Innovation Prize following its participation in the Voisin Consulting Neighborhood Program. Voisin Consulting Life Sciences is an international consulting practice that offers integrated solutions to development planning, manufacturing, quality and control, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers. Its initiative, Voisin Consulting Neighborhood, is a life …

Mount Sinai researchers advance our understanding of brain cancer

Hemerion technology introduced in the Friedman Brain Institute Falls Newsletter

Researchers from the Mount Sinai Health system introduce their ambitious research and development program to fight Glioblastoma in the recent Friedman Brain Institute Falls Newsletter, including the evaluation of the Hemerion technology. Encompassing the Icahn School of Medicine and eight hospital campuses in the New York metropolitan area, Mount Sinai is internationally acclaimed for its …

Galien Prize

Hemerion and Mount Sinai Hospital awarded the Galien MedStartup Prize for “Best Collaboration in the MedTech and Digital Health” category

Hemerion and Mount Sinai Health System (NYC) are collaborating to launch an ambitious clinical trial in 2022. This collaboration has won the “Best Collaboration in the MedTech and Digital Health” award of the Galien Medstartup Prize: an international recognition that perfectly kickstarts the Hemerion development in the USA.  The Galien Medstartup fosters, recognizes and rewards …

Brain X-Rays

Hemerion and Mount Sinai Health System nominated for the Galien MedStartup Awards 2021

Hemerion and Mount Sinai Health System have been nominated for the 8th edition of the Galien MedStartUp Awards, the innovation prize created by the Galien Foundation and Business France. The Galien Medstartup fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Since 2013, it supports the international development of …